Forbes reports, “According to a new report published by Leafly this morning, the CBD market is plagued by inaccuracies, especially when it comes to the amount of this chemical compound present in products sold across the U.S., versus what labels say.”
A few weeks ago, Simms went on her own, to launch BRN Group, a cannabis tech company with specialized focus on distribution and branding. The CEO talked about the company’s mission in an exclusive conversation with Benzinga.
A team of researchers in the United States found a link between long-term use of cannabis and the development of testicular germ cell tumors. Men with long-term cannabis use were 36 percent more likely to develop testicular cancer than those who did not use the drug.